HRS-2329 Tablet
HRS-2329-101
Phase 1 small_molecule active
Quick answer
HRS-2329 Tablet for Advanced Solid Tumors Harboring RAS Mutations or Amplifications is a Phase 1 program (small_molecule) at Jian Li with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Jian Li
- Indication
- Advanced Solid Tumors Harboring RAS Mutations or Amplifications
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active